Role of IL-1 Beta in the Development of Human T(H)17 Cells: Lesson from NLPR3 Mutated Patients

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 Jun 4

PMID 21637346

Citations 62

Authors

Denise Lasiglie

Elisabetta Traggiai

Silvia Federici

Maria Alessio

Antonella Buoncompagni

Andrea Accogli

Sabrina Chiesa

Federica Penco

Alberto Martini

Marco Gattorno

Affiliations

Soon will be listed here.

Abstract

Background: T helper 17 cells (T(H)-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1β has been indicated as a key cytokine for the commitment to T(H)-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1β secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis.

Methodology/principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T(H)17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1β, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1β blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T(H)17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T(H)17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T(H)17 frequency were observed in CAPS patients following in vivo IL-1β blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment.

Conclusion/significance: These findings further support the central role of IL-1β in the differentiation of T(H)17 in human inflammatory conditions.

Citing Articles

The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.

Zhang J, Shen M Clin Rev Allergy Immunol. 2025; 68(1):27.

PMID: 40074883 DOI: 10.1007/s12016-025-09042-5.

Immunomodulatory Tissue Factors in the Gallbladder Walls of Pediatric Patients with Chronic Calculous Cholecystitis.

Zarina K, Pilmane M, Petersons A Children (Basel). 2025; 12(2).

PMID: 40003307 PMC: 11854828. DOI: 10.3390/children12020205.

-specific TIGIT Treg are present in the blood of healthy subjects - a hurdle for vaccination?.

Clegg J, Mnich M, Carignano A, Cova G, Tavarini S, Sammicheli C Front Immunol. 2025; 15:1500696.

PMID: 39981298 PMC: 11840346. DOI: 10.3389/fimmu.2024.1500696.

Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms.

Wu Y, Sun X, Kang K, Yang Y, Li H, Zhao A J Hematol Oncol. 2024; 17(1):106.

PMID: 39511607 PMC: 11542428. DOI: 10.1186/s13045-024-01621-x.

Inhibition of Caspase 1 Reduces Blood Pressure, Cytotoxic NK Cells, and Inflammatory T-Helper 17 Cells in Placental Ischemic Rats.

Shields C, Tardo G, Wang X, Peacock G, Robbins M, Glenn H Int J Mol Sci. 2024; 25(2).

PMID: 38255935 PMC: 10815407. DOI: 10.3390/ijms25020863.

References

Wilson N, Boniface K, Chan J, McKenzie B, Blumenschein W, Mattson J . Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007; 8(9):950-7. DOI: 10.1038/ni1497. View

Hirota K, Martin B, Veldhoen M . Development, regulation and functional capacities of Th17 cells. Semin Immunopathol. 2010; 32(1):3-16. DOI: 10.1007/s00281-009-0187-y. View

Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A . Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005; 6(8):769-76. PMC: 3760217. DOI: 10.1038/ni1223. View

Neven B, Callebaut I, Prieur A, Feldmann J, Bodemer C, Lepore L . Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2003; 103(7):2809-15. DOI: 10.1182/blood-2003-07-2531. View

Mangan P, Harrington L, OQuinn D, Helms W, Bullard D, Elson C . Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006; 441(7090):231-4. DOI: 10.1038/nature04754. View

Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D . The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009; 60(3):883-91. DOI: 10.1002/art.24349. View

Hawkins P, Lachmann H, McDermott M . Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med. 2003; 348(25):2583-4. DOI: 10.1056/NEJM200306193482523. View

Veldhoen M, Hirota K, Christensen J, OGarra A, Stockinger B . Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med. 2008; 206(1):43-9. PMC: 2626686. DOI: 10.1084/jem.20081438. View

Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F . Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev. 2009; 226:112-31. PMC: 2766610. DOI: 10.1111/j.1600-065X.2008.00700.x. View

10.

Barnes M, Grom A, Thompson S, Griffin T, Pavlidis P, Itert L . Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009; 60(7):2102-12. PMC: 2782469. DOI: 10.1002/art.24601. View

11.

Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin J, Humphries S . The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7):1369-76. PMC: 508984. DOI: 10.1172/JCI2629. View

12.

OGarra A, Stockinger B, Veldhoen M . Differentiation of human T(H)-17 cells does require TGF-beta!. Nat Immunol. 2008; 9(6):588-90. DOI: 10.1038/ni0608-588. View

13.

Gerosa F, Baldani-Guerra B, Lyakh L, Batoni G, Esin S, Winkler-Pickett R . Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med. 2008; 205(6):1447-61. PMC: 2413040. DOI: 10.1084/jem.20071450. View

14.

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

15.

Lepore L, Paloni G, Caorsi R, Alessio M, Rigante D, Ruperto N . Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra. J Pediatr. 2010; 157(2):310-315.e1. DOI: 10.1016/j.jpeds.2010.02.040. View

16.

Miossec P, Korn T, Kuchroo V . Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361(9):888-98. DOI: 10.1056/NEJMra0707449. View

17.

Waldrop S, Pitcher C, Peterson D, Maino V, Picker L . Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest. 1997; 99(7):1739-50. PMC: 507995. DOI: 10.1172/JCI119338. View

18.

De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V . Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest. 1997; 99(4):643-50. PMC: 507846. DOI: 10.1172/JCI119207. View

19.

Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite N . Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum. 2007; 56(11):3793-804. DOI: 10.1002/art.22981. View

20.

Nowak E, Noelle R . Interleukin-9 as a T helper type 17 cytokine. Immunology. 2010; 131(2):169-73. PMC: 2967262. DOI: 10.1111/j.1365-2567.2010.03332.x. View